s,n,n'-tripropylthiocarbamate has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asemota, N; Berjon de la Vega, L; Bille, A; King, J; Phipps, KH; Pilling, J; Routledge, T; Saftic, I | 1 |
| Ferguson, MK | 1 |
| Bagdas, D; Bigbee, JW; Cantwell, L; Chen, ZJ; Damaj, MI; Del Fabbro, E; Gewirtz, DA; Jackson, A; Kulkarni, A; Kyte, SL; Meade, JA; Papke, RL; Rahman, F; Thakur, GA; Toma, W | 1 |
3 other study(ies) available for s,n,n'-tripropylthiocarbamate and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Risks and rewards of the surgical treatment of lung cancer in octogenarians.
Topics: Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplasm Staging; Octogenarians; Pneumonectomy; Retrospective Studies; Reward; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2021 |
Small Modifications in Technique May Yield Large Rewards After Lung Cancer Surgery.
Topics: Arteries; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplastic Cells, Circulating; Propensity Score; Registries; Reward | 2019 |
The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal.
Topics: A549 Cells; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Tolerance; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nicotine; Nicotinic Agonists; Paclitaxel; Peripheral Nervous System Diseases; Piperazines; Reward | 2019 |